Matthew Cooperberg, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Steba
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astra Zeneca
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    MDx Health
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GenomeDx
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myriad Genetics
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    10/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Steba
    Date added:
    Date updated:
    10/22/2024

Pages

Return to Active Surveillance for Prostate Cancer (2019)